SRI-42127 is an experimental drug which acts to inhibit translocation of the RNA-binding HuR protein. HuR translocation promotes the production of inflammatory cytokines in glial cells, and inhibiting HuR has applications both in the treatment of some forms of cancer, and also neuropathic pain.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.